Moderate- to low-risk variant alleles of cutaneous malignancies and nevi: Lessons from genome-wide association studies

Genome Medicine

Volumn 1, Issue 10, 2009, Pages

  Udayakumar, Durga ^a,b   Tsao, Hensin ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI PROTEIN; B RAF KINASE; MELANOCORTIN 1 RECEPTOR; ONCOPROTEIN; TWO PORE SEGMENT CHANNEL 2; UNCLASSIFIED DRUG;

BASAL CELL CARCINOMA; CANCER RISK; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAIR COLOR; HUMAN; MELANOCYTIC NEVUS; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; SKIN COLOR;

EID: 77952403738     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm95     Document Type: Short Survey

References (37)

1. SEER Database [http://seer.cancer.gov/statfacts/html/skin.html]
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J,Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
3. Roderick McLeod G, Davis NC, Sober AJ: A history of melanoma: From Hunter to Clark. In Cutaneous Melanoma. 4th edition. Edited by Balch CM, Houghton AN, Sober AJ, Soong S-j. St Louis: Quality Medical Publishing, Inc.; 2003:2-12.
4. Clark WH Jr, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ: Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol 1978, 114:732-738.
5. Lynch HT, Frichot BC 3rd, Lynch JF: Familial atypical multiple mole-melanoma syndrome. J Med Genet 1978, 15:352-356.
6. Wainwright B: Familial melanoma and p16 - a hung jury. Nat Genet 1994, 8:3-5.
7. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracopoli NC: Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996, 12:97-99.
8. Udayakumar D, Tsao H: Melanoma genetics: an update on risk-associated genes. Hematol Oncol Clin North Am 2009, 23: 415-429, vii.
9. Bishop JN, Harland M, Bishop DT: The genetics of melanoma. Br J Hosp Med (Lond) 2006, 67:299-304.
10. Chin L, Garraway LA, Fisher DE: Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 2006, 20:2149-2182.
11. Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W,Calista D, Albright LA, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, MacKie RM, Magnusson V, Mann GJ, et al.: Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 2007, 44:99-106.
12. Stacey S.N., Sulem P., Masson G, Gudjonsson S.A., Thorleifsson G., Jakobsdottir M, Sigurdsson A., Gudbjartsson D.F., Sigurgeirsson B., Benediktsdottir K.R., Thorisdottir K., Ragnarsson R, Scherer D., Hemminki K, Rudnai P., Gurzau E, Koppova K., Botella-Estrada R, Soriano V., Juberias P, Saez B., Gilaberte Y, Fuentelsaz V., Corredera C, Grasa M., Hoiom V, Lindblom A.Bonenkamp J.J., van Rossum MM, Aben KK, et al.: New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009, 41:909-914.
13. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, Boyle P, Melchi CF: Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005, 41: 2040-2059.
14. Lin J, Hocker TL, Singh M, Tsao H: Genetics of melanoma predisposition. Br J Dermatol 2008, 159:286-291.
15. Rouzaud F, Kadekaro AL, Abdel-Malek ZA, Hearing VJ: MC1R and the response of melanocytes to ultraviolet radiation. Mutat Res 2005, 571:133-152.
16. Garcia-Borron JC, Sanchez-Laorden BL, Jimenez-Cervantes C: Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 2005, 18:393-410.
17. Mas JS, Gerritsen I, Hahmann C, Jimenez-Cervantes C, Garcia-Borron JC: Rate limiting factors in melanocortin 1 receptor signalling through the cAMP pathway. Pigment Cell Res 2003, 16:540-547.
18. Valverde P, Healy E, Jackson I, Rees JL,Thody AJ: Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 1995, 11:328-330.
19. Raimondi S, Sera F, Gandini S, Iodice S, Caini S, Maisonneuve P,Fargnoli MC: MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 2008, 122:2753-2760.
20. Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA, Hayward NK: MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001, 69:765-773.
21. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN: Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001, 117:294-300.
22. Fargnoli MC, Pike K, Pfeiffer RM, Tsang S, Rozenblum E, Munroe DJ, Golubeva Y, Calista D, Seidenari S, Massi D, Carli P, Bauer J, Elder DE, Bastian BC, Peris K, Landi MT: MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol 2008, 128:2485-2490.
23. Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P, Calista D, Kanetsky PA, Pinkel D, Bastian BC: MC1R germline variants confer risk for BRAF-mutant melanoma. Science 2006, 313:521-522.
24. Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Magnusson KP, Manolescu A, Karason A, Palsson A, Thorleifsson G, Jakobsdottir M, Steinberg S, Palsson S, Jonasson F, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Aben KK, Kiemeney LA, Olafsson JH, Gulcher J, Kong A, Thorsteinsdottir, U,Stefansson, K: Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet 2007, 39:1443-1452.
25. Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Jakobsdottir M, Steinberg S, Gudjonsson SA, Palsson A, Thorleifsson G, Palsson S, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Aben KK, Vermeulen SH, Goldstein AM, Tucker MA, Kiemeney LA, Olafsson JH, GulcherJ, Kong A, Thorsteinsdottir U,Stefansson K: Two newly identified genetic determinants of pigmentation in Europeans. Nat Genet 2008, 40:835-837.
26. Gudbjartsson DF, Sulem P, Stacey SN, Goldstein AM, Rafnar T, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Sveinsdottir SG, Magnusson V, Lindblom A, Kostulas K, Botella-Estrada R, Soriano V, Juberias P, Grasa M, Saez B, Andres R, Scherer D, Rudnai P, Gurzau E, Koppova K, Kiemeney LA, Jakobsdottir M, Steinberg S, Helgason A, Gretarsdottir S, Tucker MA, Mayordomo JI, et al.: ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 2008, 40: 886-891.
27. Brown KM, Macgregor S, Montgomery GW, Craig DW, Zhao ZZ, Iyadurai K, Henders AK, Homer N, Campbell MJ, Stark M, Thomas S, Schmid H, Holland EA, Gillanders EM, Duffy DL, Maskiell JA, Jetann J, Ferguson M, Stephan DA, Cust AE, Whiteman D, Green A, Olsson H, Puig S, Ghiorzo P, Hansson J, Demenais F, Goldstein AM, Gruis NA, Elder DE, et al.: Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet 2008, 40:838-840.
28. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, Randerson-Moor J, Aitken JF, Avril MF, Azizi E, Bakker B, Bianchi-Scarra G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Chin AWT, Debniak T, Galore-Haskel G, Ghiorzo P, Gut I, Hansson J, Hocevar M, Hoiom V, Hopper JL, Ingvar C, Kanetsky PA, Kefford RF, Landi MT, Lang J, Lubinski J, et al.: Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009, 41:920-925.
29. Han J, Kraft P, Nan H, Guo Q, Chen C, Qureshi A, Hankinson SE, Hu FB, Duffy DL, Zhao ZZ, Martin NG, Montgomery GW, Hayward NK, Thomas G, Hoover RN, Chanock S, Hunter DJ: A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet 2008, 4:e1000074.
30. Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, Bale AE, Bale SJ: Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997, 69:299-308.
31. Shanley S, Ratcliffe J, Hockey A, Haan E, Oley C, Ravine D, Martin N, Wicking C, Chenevix-Trench G: Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet 1994, 50:282-290.
32. Stacey SN, Gudbjartsson DF, Sulem P, Bergthorsson JT, Kumar R, Thorleifsson G, Sigurdsson A, Jakobsdottir M, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Scherer D, Rudnai P, Gurzau E, Koppova K, Hoiom V, Botella-Estrada R, Soriano V, Juberias P, Grasa M, Carapeto FJ, Tabuenca P, Gilaberte Y, Gudmundsson J, Thorlacius S, Helgason A, Thorlacius T, Jonasdottir A, Blondal T, et al.: Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits. Nat Genet 2008, 40:1313-1318.
33. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, Melchi CF: Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005, 41:28-44. 34.
34. MacKie RM, McHenry P, Hole D: Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet 1993, 341:1618-1620.
35. Falchi M, Spector TD, Perks U, Kato BS, Bataille V: Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort. Hum Mol Genet 2006, 15: 2975-2979.
36. Zhu G, Montgomery GW, James MR, Trent JM, Hayward NK, Martin NG, Duffy DL: A genome-wide scan for naevus count: linkage to CDKN2A and to other chromosome regions. Eur J Hum Genet 2007, 15:94-102.
37. Falchi M, Bataille V, Hayward NK, Duffy DL, Bishop JA, Pastinen T, Cervino A, Zhao ZZ, Deloukas P, Soranzo N, Elder DE, Barrett JH, Martin NG, Bishop DT, Montgomery GW, Spector TD: Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet 2009, 41:915-919.